NA
CL icon

Navellier & Associates’s Colgate-Palmolive CL Stock Holding History

Navellier & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
26,065
+682
+3% +$59.7K 0.19% 115
2026
Q1 		$2.16M Sell
25,383
-1,170
-4% -$104K 0.23% 103
2025
Q4 		$2.1M Sell
26,553
-3,254
-11% -$255K 0.24% 97
2025
Q3 		$2.38M Buy
29,807
+680
+2% +$58K 0.24% 100
2025
Q2 		$2.65M Sell
29,127
-146
-0.5% -$13.3K 0.33% 83
2025
Q1 		$2.66M Sell
29,273
-3,397
-10% -$304K 0.37% 74
2024
Q4 		$2.97M Buy
32,670
+1,952
+6% +$186K 0.36% 77
2024
Q3 		$3.19M Sell
30,718
-1,692
-5% -$172K 0.43% 62
2024
Q2 		$3.15M Sell
32,410
-515
-2% -$47.5K 0.37% 70
2024
Q1 		$2.96M Sell
32,925
-2,152
-6% -$182K 0.37% 74
2023
Q4 		$2.8M Sell
35,077
-373
-1% -$28K 0.42% 74
2023
Q3 		$2.52M Sell
35,450
-2,403
-6% -$180K 0.43% 79
2023
Q2 		$2.92M Sell
37,853
-406
-1% -$31.4K 0.57% 69
2023
Q1 		$2.88M Sell
38,259
-340
-0.9% -$25.3K 0.6% 64
2022
Q4 		$3.04M Buy
38,599
+3,148
+9% +$236K 0.62% 56
2022
Q3 		$2.49M Sell
35,451
-328
-0.9% -$25.7K 0.55% 60
2022
Q2 		$2.87M Buy
35,779
+1,602
+5% +$125K 0.62% 60
2022
Q1 		$2.59M Buy
34,177
+1,892
+6% +$150K 0.44% 79
2021
Q4 		$2.75M Sell
32,285
-1,257
-4% -$98.2K 0.4% 77
2021
Q3 		$2.54M Sell
33,542
-201
-0.6% -$16K 0.38% 81
2021
Q2 		$2.75M Buy
33,743
+1,994
+6% +$163K 0.41% 79
2021
Q1 		$2.5M Sell
31,749
-25,050
-44% -$1.96M 0.45% 75
2020
Q4 		$4.86M Buy
56,799
+6,263
+12% +$518K 0.88% 33
2020
Q3 		$3.9M Sell
50,536
-1,890
-4% -$144K 0.85% 37
2020
Q2 		$3.84M Buy
+52,426
New +$3.72M 0.91% 32

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Navellier & Associates's CL Position: Q2 2026 in Review

Navellier & Associates increased its Colgate-Palmolive (CL) stake by 2.7% in Q2 2026, buying an estimated $59.7K and bringing the position to 26,065 shares worth $2.39M. The position accounts for 0.19% of the portfolio, ranked #115.

Navellier & Associates first reported a position in CL in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.86M in Q4 2020. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Navellier & Associates held 26,065 shares of Colgate-Palmolive worth $2.39M as of Q2 2026.
  • Navellier & Associates bought 682 Colgate-Palmolive shares in Q2 2026, an estimated $59.7K.
  • Colgate-Palmolive made up 0.19% of Navellier & Associates's portfolio in Q2 2026, its #115 holding.
  • Navellier & Associates first reported a position in Colgate-Palmolive in Q2 2020 and has held it in 25 quarters since.
  • Navellier & Associates's Colgate-Palmolive position peaked at $4.86M in Q4 2020.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.